Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Basic) (2016 - 2025)

Prestige Consumer Healthcare has reported EPS (Basic) over the past 16 years, most recently at $0.98 for Q4 2025.

  • Quarterly results put EPS (Basic) at $0.98 for Q4 2025, down 20.33% from a year ago — trailing twelve months through Dec 2025 was $3.81 (down 11.6% YoY), and the annual figure for FY2025 was $4.32, up 2.61%.
  • EPS (Basic) for Q4 2025 was $0.98 at Prestige Consumer Healthcare, up from $0.86 in the prior quarter.
  • Over the last five years, EPS (Basic) for PBH hit a ceiling of $1.23 in Q4 2024 and a floor of -$4.82 in Q1 2023.
  • Median EPS (Basic) over the past 5 years was $1.02 (2022), compared with a mean of $0.72.
  • Biggest five-year swings in EPS (Basic): tumbled 563.46% in 2023 and later surged 120.75% in 2024.
  • Prestige Consumer Healthcare's EPS (Basic) stood at $1.0 in 2021, then increased by 5.0% to $1.05 in 2022, then rose by 1.9% to $1.07 in 2023, then grew by 14.95% to $1.23 in 2024, then decreased by 20.33% to $0.98 in 2025.
  • The last three reported values for EPS (Basic) were $0.98 (Q4 2025), $0.86 (Q3 2025), and $0.96 (Q2 2025) per Business Quant data.